Skip to content

Value of platelet function testing technology in the prevention of thrombosis in the middle-age and old population

Value of platelet function testing technology in the prevention of thrombosis in the middle-age and old population

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017549
Enrollment
Unknown
Registered
2018-08-03
Start date
2018-09-01
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thrombotic diseases

Interventions

Case series:Nil

Sponsors

Henan Provincial People's Hospital, Zhengzhou University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Males aged 50-90 years or non-pregnant or lactating women; 2. Basically health; 3. Volunteers agree to participate in the trial. And signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Disability, apparently in non-health or disease state; 2. More severe heart, liver, kidney, lung insufficiency, total bilirubin > 3 times normal value, aspartate aminotransferase (AST) or alanine aminotransferase (ALT) > 3 times normal value; 3. History of severe allergic reaction; 4. Nervous system disease or poor mental condition (including epilepsy, depression, other history of mental illness, etc.); 5. Known or confirmed serum HIV positive, syphilis antibody positive, Hepatitis B, hepatitis C or other serious infectious disease volunteers; 6. People with cognitive dysfunction, or unable to understand and sign informed consent; 7. Coagulone dysfunction and volunteers who are about to use or are using anticoagulant drugs; 8. Volunteers who experienced other operations, bruises, trauma (including fractures) within the past month or during the trial; 9. This test/physical examination will change the application of antiplatelet drugs and doses; 10. With malignant tumors or infectious disease.

Design outcomes

Primary

MeasureTime frame
MAR;PLT-0;

Secondary

MeasureTime frame
MPV-0;

Countries

China

Contacts

Public ContactNingmin Zhao

Zhengzhou University People's Hospital, He'nan Provincial People's Hospital

znm188@188.com+86 13513807401

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026